Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Latent transforming growth factor beta 1 (TGF-β1) is a secreted cytokine and a member of the transforming growth factor beta superfamily. It plays critical roles in regulating cell proliferation, differentiation, apoptosis, immune responses, and tissue remodeling. TGF-β1 is synthesized as a large precursor protein that undergoes proteolytic processing to yield a mature peptide. Before secretion, it associates non-covalently with its propeptide called latency-associated peptide (LAP), forming the small latent complex. This complex can further bind covalently to latent TGF-β binding proteins (LTBPs), resulting in the large latent complex that anchors TGF-β1 within the extracellular matrix. Latent TGF-β1 requires activation to exert its biological effects through mechanisms such as integrin-mediated force/conformational change and MMP-dependent cleavage.
Inhibition of TGF-β1 activation or signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latent Transforming Growth Factor Beta 1 (TGF-β1).